NEW YORK, May 10, 2019 /PRNewswire/ -- Chardan, a global
investment bank, announced today that the firm acted as lead left
joint book runner in the initial public offering of Health Sciences
Acquisitions Corporation (NASDAQ: HSACU), raising aggregate gross
proceeds of $115 million, including
exercise of the over-allotment. Health Sciences Acquisitions
Corporation began trading on the NASDAQ Capital Market on
May 10, 2019 and is sponsored by an
affiliate of RTW Investments, LP ("RTW"), a New York based financial firm with more than
$1.9 billion of regulatory assets
under management, as of January 2,
2019.
Health Sciences Acquisitions Corporation is the third
healthcare-focused special purpose acquisition company ("SPAC") to
IPO in the past twelve months. Chardan previously sponsored and was
sole book-running manager of Chardan Healthcare Acquisition Corp.
(NYSE American: CHAC.U), which began trading on December 14, 2018. Chardan also acted as lead
manager in ARYA Sciences Acquisition Corp. (NASDAQ: ARYAU), which
began trading on October 5, 2018.
"Strong market reception to Health Sciences is a testament to
the RTW team and to the value a SPAC provides as a financing
alternative for growing biotech companies. We believe the
opportunity to leverage SPACs in biotech is extraordinary," noted
George Kaufman, Partner and Head of
Investment Banking with Chardan.
Chardan has participated in advisory and capital raising
transactions totaling more than $700
million year to date in 2019.
About Chardan
Chardan is an independent global investment bank specializing in
healthcare, SPACs and emerging growth companies. Our range of
services include capital raising, merger and acquisition advisory,
strategic advisory, equity research, corporate access and
institutional trading. Headquartered in New York City, Chardan is a registered
broker-dealer with the U.S. Securities and Exchange Commission and
is a member of the following: FINRA, SIPC, NASDAQ and the NYSE
Arca, Inc.
Learn more about Chardan: www.chardan.com
Media Contact:
Emily
Levine, Chardan
elevine@chardan.com
(646) 465-9018
Tom Rozycki, Prosek Partners
trozycki@prosek.com
(646) 818-9208
View original
content:http://www.prnewswire.com/news-releases/chardan-serves-as-lead-left-joint-book-running-manager-for-health-sciences-acquisitions-corporation-300848142.html
SOURCE Chardan Capital Markets, LLC